ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000258413.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.006286281	Sensitive
ENSG00000258413.1	ABT-263 (navitoclax)	Sarcoma	0.039039305	Sensitive